Back
Xvivo Perfusion AB Vs. RH Industry Stock Comparison
Buy
57
XVIPF
Xvivo Perfusion AB
Last Price:
$41.10
Seasonality Move:
-0.25%
Buy
64
RH
RH
Last Price:
$405.18
Seasonality Move:
-4.26%
Buy
57
Xvivo Perfusion AB (XVIPF)
is a Buy
Is Xvivo Perfusion AB a Buy, Sell or Hold?
-
The current Xvivo Perfusion AB [XVIPF] share price is $41.10. The Score for XVIPF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
XVIPF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XVIPF Stock Price Chart
What is Xvivo Perfusion AB's stock price today?
-
The Xvivo Perfusion AB share price today is $41.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XVIPF is experiencing slight buying pressure.
XVIPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 25.95 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.14 - 42.94) | Sell |
Bollinger Bands (100): | (41.93 - 49.09) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.35 | Buy |
Relative Strength Index (14 RSI): | 56.55 | Buy |
Chaikin Money Flow: | 311777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (379.48 - 411.46) | Buy |
Bollinger Bands (100): | (282.95 - 381.69) | Buy |
XVIPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.1 | Sell |
20-day SMA: | 41.82 | Sell |
50-day SMA: | 42.23 | Sell |
200-day SMA: | 41.71 | Sell |
8-day EMA: | 41.19 | Sell |
20-day EMA: | 41.59 | Sell |
50-day EMA: | 42.7 | Sell |
200-day EMA: | 40.93 | Buy |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 401.89 | Buy |
20-day SMA: | 399.03 | Buy |
50-day SMA: | 364.22 | Buy |
200-day SMA: | 298.98 | Buy |
8-day EMA: | 399.99 | Buy |
20-day EMA: | 394.55 | Buy |
50-day EMA: | 371.42 | Buy |
200-day EMA: | 317.06 | Buy |
Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.79 per share, a decrease this year of $2.09 per share, and an increase next year of $6.94 per share.
Xvivo Perfusion AB Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |